Darlene Dobkowski, Managing Editor for CURE® magazine, has been with the team since October 2020 and has covered health care in other specialties before joining MJH Life Sciences. She graduated from Emerson College with a Master’s degree in print and multimedia journalism. In her free time, she enjoys buying stuff she doesn’t need from flea markets, taking her dog everywhere and scoffing at decaf.
Mental Health Linked to Emotional and Physical Distress in Older Patients With Metastatic Cancer
April 12th 2023Some factors may increase the risk for anxiety and depression in older patients with metastatic cancer including distress related to physical symptoms, relationships, healthy lifestyle and communication with their health care team.
Read More
Educated Patient® Breast Cancer Summit at MBCC Early-Stage HER2-Positive Presentation: March 4, 2023
March 30th 2023Watch Dr. Naomi Dempsey, from Miami Cancer Institute, discuss the management of HER2-positive, early-stage disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.
Read More
Chemo-Related Hearing Loss Is Common in Survivors of Testicular Cancer, Other Cancer Types
March 6th 2023With 74% of testicular cancer survivors reporting hearing loss in a recent study, one expert advised patients to advocate for themselves and their hearing before, during and after cancer treatment with cisplatin-based chemotherapy.
Read More
FDA Expands Verzenio Indication to Forego Ki-67 Score in High-Risk, Early Breast Cancer
March 6th 2023Removing the Ki-67 score to determine eligibility for Verzenio treatment in patients with HR-positive, HER2-negative, node positive, early breast cancer allows for more patients to receive this treatment.
Read More
Older Patients With Diabetes May Have 1.5-Fold Increased Risk for Death From Cancer
February 22nd 2023Patients with type 2 diabetes have an increased cancer burden and, as a result, a higher mortality rate, highlighting the importance of inflammatory factors like obesity and glucose control.
Read More
Protecting Heart Health During, After Cancer Treatment and Into Survivorship
February 14th 2023Cancer treatments including chemotherapy and radiation may increase a patient’s risk for heart disease, and being mindful of some of the symptoms may be one of the steps for prevention, one expert said.
Read More
First Patients Dosed With Novel Inhibitor in Trial on Relapsed or Refractory AML Subset
February 11th 2023Researchers conducting a phase 2 trial recently dosed the first patients with a novel menin inhibitor for the treatment of patients with NPM1-mutant relapsed or refractory acute myeloid leukemia.
Read More